Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases

Food and Chemical Toxicology

Volumn 48, Issue 4, 2010, Pages 1052-1058

  Yang, Shun Fa ^a,b   Chen, Mu Kuan ^a,c,d   Hsieh, Yih Shou ^a   Yang, Jia Sin ^a   Zavras, Athanasios I ^e   Hsieh, Yih Hsien ^a   Su, Shih Chi ^f   Kao, Te Yu ^a   Chen, Pen Ni ^a   Chu, Shu Chen ^g  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d MINGDAO UNIVERSITY   (Taiwan)

^e New York Presbyterian Hospital   (United States)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^g CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Invasion; MMP 2; Motility; Oral cancer; Terminalia catappa; u PA

Indexed keywords

ANTIMETASTATIC AGENT; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PLANT EXTRACT; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; TERMINALIA CATAPPA EXTRACT; UNCLASSIFIED DRUG; UROKINASE;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; TAIWAN; TERMINALIA; TERMINALIA CATAPPA; WESTERN BLOTTING; ZYMOGRAPHY;

ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PEPTIDE HYDROLASES; PLANT EXTRACTS; TERMINALIA; TETRAZOLIUM SALTS; THIAZOLES; TONGUE NEOPLASMS;

TERMINALIA CATAPPA;

EID: 77549086838     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.01.019     Document Type: Article

References (41)

1. Aguirre Ghiso J.A., Alonso D.F., Farias E.F., Gomez D.E., and de Kier Joffe E.B. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem. 263 (1999) 295-304
2. Bjorklund M., and Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 1755 (2005) 37-69
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Chen F., Castranova V., and Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am. J. Pathol. 159 (2001) 387-397
5. Chen P.N., Hsieh Y.S., Chiang C.L., Chiou H.L., Yang S.F., and Chu S.C. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res. 85 (2006) 220-225
6. Chen P.N., Hsieh Y.S., Chiou H.L., and Chu S.C. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem. Biol. Interact. 156 (2005) 141-150
7. Chen P.S., Li J.H., Liu T.Y., and Lin T.C. Folk medicine Terminalia catappa and its major tannin component, punicalagin, are effective against bleomycin-induced genotoxicity in Chinese hamster ovary cells. Cancer Lett. 152 (2000) 115-122
8. Chu S.C., Yang S.F., Liu S.J., Kuo W.H., Chang Y.Z., and Hsieh Y.S. In vitro and in vivo antimetastatic effects of Terminalia catappa L. Leaves on lung cancer cells. Food Chem. Toxicol. 45 (2007) 1194-1201
9. Fan Y.M., Xu L.Z., Gao J., Wang Y., Tang X.H., Zhao X.N., and Zhang Z.X. Phytochemical and antiinflammatory studies on Terminalia catappa. Fitoterapia 75 (2004) 253-260
10. Gao J., Dou H., Tang X.H., Xu L.Z., Fan Y.M., and Zhao X.N. Inhibitory effect of TCCE on CCl4-induced overexpression of IL-6 in acute liver injury. Acta Biochim. Biophys. Sin. (Shanghai) 36 (2004) 767-772
11. Hsiao Y.C., Kuo W.H., Chen P.N., Chang H.R., Lin T.H., Yang W.E., Hsieh Y.S., and Chu S.C. Flavanone and 2′-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Chem. Biol. Interact. 167 (2007) 193-206
12. Hsieh Y.S., Chu S.C., Yang S.F., Chen P.N., Liu Y.C., and Lu K.H. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis 28 (2007) 977-987
13. Jia W., Gao W., and Tang L. Antidiabetic herbal drugs officially approved in China. Phytother. Res. 17 (2003) 1127-1134
14. Kim D., Kim S., Koh H., Yoon S.O., Chung A.S., Cho K.S., and Chung J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 15 (2001) 1953-1962
15. Kim J., Yu W., Kovalski K., and Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94 (1998) 353-362
16. Li X., and Wang H. Chinese herbal medicine in the treatment of chronic kidney disease. Adv. Chronic Kidney Dis. 12 (2005) 276-281
17. Libra M., Scalisi A., Vella N., Clementi S., Sorio R., Stivala F., Spandidos D.A., and Mazzarino C. Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int. J. Oncol. 34 (2009) 897-903
18. Lin C.C., Chen Y.L., Lin J.M., and Ujiie T. Evaluation of the antioxidant and hepatoprotective activity of Terminalia catappa. Am. J. Chin. Med. 25 (1997) 153-161
19. Mackay A.R., Corbitt R.H., Hartzler J.L., and Thorgeirsson U.P. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res. 50 (1990) 5997-6001
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
21. Nelson A.R., Fingleton B., Rothenberg M.L., and Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18 (2000) 1135-1149
22. Nyberg P., Moilanen M., Paju A., Sarin A., Stenman U.H., Sorsa T., and Salo T. MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J. Dent. Res. 81 (2002) 831-835
23. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1104-1117
24. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3 (2003) 489-501
25. Rothhammer T., Hahne J.C., Florin A., Poser I., Soncin F., Wernert N., and Bosserhoff A.K. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell. Mol. Life Sci. 61 (2004) 118-128
26. Sliva D. Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr. Cancer Drug Targets 4 (2004) 327-336
27. Spiro R.H., Alfonso A.E., Farr H.W., and Strong E.W. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am. J. Surg. 128 (1974) 562-567
28. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2 (2002) 573-583
29. Stetler-Stevenson W.G., Aznavoorian S., and Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9 (1993) 541-573
30. Takada Y., Singh S., and Aggarwal B.B. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem. 279 (2004) 15096-15104
31. Tanaka T., Nonaka G.I., Ishimatsu M., Nishioka I., and Kouno I. Revised structure of cercidinin A, a novel ellagitannin having (R)-hexahydroxydiphenoyl esters at the 3, 4-positions of glucopyranose. Chem. Pharm. Bull. (Tokyo) 49 (2001) 486-487
32. Tang X.H., Gao J., Wang Y.P., Xu L.Z., Zhao X.N., and Xu Q. Hepatoprotective effects of chloroform extract from leaf of Terminalia catappa in relation to the inhibition of liver IL-6 expression. Zhongguo. Zhong. Yao. Za. Zhi. 28 (2003) 1170-1174
33. Tryggvason K., Hoyhtya M., and Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta 907 (1987) 191-217
34. Weiss L. Metastatic inefficiency. Adv. Cancer Res. 54 (1990) 159-211
35. Weng C.J., Chau C.F., Hsieh Y.S., Yang S.F., and Yen G.C. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29 (2008) 147-156
36. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
37. Yang S.F., Chu S.C., Liu S.J., Chen Y.C., Chang Y.Z., and Hsieh Y.S. Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo. J. Ethnopharmacol. 110 (2007) 483-489
38. Yang S.F., Hsieh Y.S., Lin C.L., Hsu N.Y., Chiou H.L., Chou F.P., and Chu S.C. Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clin. Chim. Acta 354 (2005) 91-99
39. Yang S.F., Yang W.E., Chang H.R., Chu S.C., and Hsieh Y.S. Luteolin induces apoptosis in oral squamous cancer cells. J. Dent. Res. 87 (2008) 401-406
40. Yang S.F., Yang W.E., Kuo W.H., Chang H.R., Chu S.C., and Hsieh Y.S. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch. Oral Biol. 53 (2008) 287-294
41. Yoon S.O., Park S.J., Yun C.H., and Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 36 (2003) 128-137